NCT03925311 Transcriptome Profiling and Endometrial Receptivity
| NCT ID | NCT03925311 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Pregnancy Related |
| Study Type | OBSERVATIONAL |
| Enrollment | 220 participants |
| Start Date | 2015-04-20 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 220 participants in total. It began in 2015-04-20 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to correlate and identify the biochemical markers which may reflect WOI. Blood samples will be collected and endometrial biopsy will be performed at particular time points.
Eligibility Criteria
Inclusion Criteria: Age 20-40 years. Exclusion Criteria: * Uncorrected uterine anomalies, such as septate or bicornuate uterus, fibroids (submucous/intramural). * Intrauterine adhesions. * Adenomyosis.
Contact & Investigator
Pui Wah Jacqueline Chung, MBBS
PRINCIPAL INVESTIGATOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT03925311 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 40 Years, studying Pregnancy Related. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03925311 currently recruiting?
Yes, NCT03925311 is actively recruiting participants. Contact the research team at margaretlee@cuhk.edu.hk for enrollment information.
Where is the NCT03925311 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT03925311 clinical trial?
NCT03925311 is sponsored by Chinese University of Hong Kong. The principal investigator is Pui Wah Jacqueline Chung, MBBS at Chinese University of Hong Kong. The trial plans to enroll 220 participants.